Sulfonylureas and glinides showed low cancer risks for breast, prostate, renal, and hepatic cancers and can be proposed in gastric cancer or in glioma, where the upregulation of the ABCC8 gene has been associated with poor prognosis (Mao et al., 2019). This evidence concerns the gene ABCC8 and glioma.